In addition, a meta-analysis of 1193 patients with baseline SGLT2i use in AMPLITUDE-O and Harmony Outcomes revealed an HR for MACE of 0.78 (95% CI 0.491.24) with SGLT2is and 0.77 (95% CI 0.680.87) without SGLT2is ( P -value for interaction 0.95), and an HR for HHF of 0.34 (95% CI 0.120.96) with SGLT2is and 0.72 (95% CI 0.550.92) without SGLT2is ( P -value for interaction 0.18) [48]
After I received my first injection, I started experiencing nausea the same day, which continued for several days
Prez de la Lastra et al., 2021)
By mimicking GLP-1, tirzepatide increases insulin secretion, reduces glucagon release, and slows gastric emptying
Available at: [5] Rosen, C
The key is portion controlsmall amounts distributed throughout the day are better tolerated than large, fatty meals